| Title |
Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer
|
|---|---|
| Published in |
PharmacoEconomics, August 2014
|
| DOI | 10.1007/s40273-014-0206-2 |
| Pubmed ID | |
| Authors |
Nigel Fleeman, Adrian Bagust, Sophie Beale, Kerry Dwan, Rumona Dickson, Chris Proudlove, Yenal Dundar |
Mendeley readers
The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 3 | 2% |
| Ecuador | 2 | 2% |
| Canada | 1 | <1% |
| Unknown | 121 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 22 | 17% |
| Student > Master | 18 | 14% |
| Researcher | 17 | 13% |
| Student > Bachelor | 13 | 10% |
| Other | 9 | 7% |
| Other | 22 | 17% |
| Unknown | 26 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 39% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 10% |
| Nursing and Health Professions | 6 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 5% |
| Social Sciences | 5 | 4% |
| Other | 18 | 14% |
| Unknown | 30 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2018.
All research outputs
#4,690,194
of 22,760,687 outputs
Outputs from PharmacoEconomics
#478
of 1,816 outputs
Outputs of similar age
#47,983
of 235,611 outputs
Outputs of similar age from PharmacoEconomics
#8
of 34 outputs
Altmetric has tracked 22,760,687 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,816 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,611 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.